COX-2 (mouse) Polyclonal Antiserum

COX-2 (mouse) Polyclonal Antiserum （订货以CAS编码或英文名称为准）

Application|Fluorescence||Application|Immunofluorescence||Application|Immunohistochemistry||Application|Western Blot||Product Type|Antibodies|Primary Antibodies|Polyclonal Antibodies||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway

创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载

编号：PC55249

分子式：C19H20FNO3

CAS号：1396174-70-1

分子量：329.37

储存条件：-20

申请试用

货号	品牌	规格	纯度/含量	标准价	优惠价
PC55249-10mg	Medlife	10mg	≥95%	待询	登录后可见
PC55249-25mg	Medlife	25mg	≥95%	待询	登录后可见
PC55249-50mg	Medlife	50mg	≥95%	待询	登录后可见
PC55249-100mg	Medlife	100mg	≥95%	待询	登录后可见
PC55249-100µl	Medlife	EA		¥4307.00	登录后可见

中文名称：	帕罗西汀杂质6
英文名称：	COX-2 (mouse) Polyclonal Antiserum
英文别名：	HST9DZF5RY;7VV49X7XV6;Paroxetine, cis-(+)-;Paroxetine, cis-(-)-;Paroxetine, cis-(+/-)-;Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3R,4R)-;Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3R,4R)-rel-;Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3R,4R)-rel-(+)-;Piperidine,
CAS号：	1396174-70-1
分子式：	C19H20FNO3
分子量：	329.37
详细描述	Application\|Fluorescence\|\|Application\|Immunofluorescence\|\|Application\|Immunohistochemistry\|\|Application\|Western Blot\|\|Product Type\|Antibodies\|Primary Antibodies\|Polyclonal Antibodies\|\|Research Area\|Immunology & Inflammation\|Inflammatory Lipid Mediators\|Prostaglandins\|\|Research Area\|Lipid Biochemistry\|Cyclooxygenase Pathway

搜索质检报告(COA)

相关产品

((3R,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol compound with ((3S,4S)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol (1:1) hydrochloride

(trans)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro- [1,1'-biphenyl]-4-yl)piperidine-1-carboxylate

(trans)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- methoxyphenyl)piperidine-1-carboxylate

(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound with (3S,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine(1:1) hydrochloride

(3S,3'S,4R,4'R)-diphenyl 3,3'-(oxybis(methylene))bis(4-(4- fluorophenyl)piperidine-1-carboxylate)

(3S,4R)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-phenyl piperidine-1-carboxylate

((cis)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methyl 4-methylbenzenesulfonate

(3S,3'S,4R,4'R)-3,3'-(oxybis(methylene))bis(4-(4-fluorophenyl)-1- methylpiperidine)

(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro-[1,1'- biphenyl]-3-yl)piperidine hydrochloride

(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro-[1,1'-biphenyl]-4-yl)-1-methylpiperidine hydrochloride